Hoth Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HOTH and other ETFs, options, and stocks.

About HOTH

Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. 

CEO
Robbie Knie
CEORobbie Knie
Employees
4
Employees4
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2017
Founded2017
Employees
4
Employees4

HOTH Key Statistics

Market cap
6.58M
Market cap6.58M
Price-Earnings ratio
-0.13
Price-Earnings ratio-0.13
Dividend yield
Dividend yield
Average volume
2.51M
Average volume2.51M
High today
$1.55
High today$1.55
Low today
$1.35
Low today$1.35
Open price
$1.40
Open price$1.40
Volume
254.52K
Volume254.52K
52 Week high
$4.30
52 Week high$4.30
52 Week low
$0.99
52 Week low$0.99

HOTH News

Yahoo Finance 1d
Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment - Yahoo Finance

Merveille.ai Files Patent for Obesity Treatment, Begins Preparatory Steps for Clinical Trials, Joins Nvidia Developer Program NEW YORK, March 27, 2024 /PRNewsw...

Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.